Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model
Open Access
Abstract
Background: The rapid genetic evolution of SARS-CoV-2 has led to the emergence of immune-evading, highly transmissible variants of concern (VOCs). This prompts the need for next-generation vaccines that elicit robust mucosal immunity in the airways to directly curb viral infection. Objective: Here, we investigate the impact of heterologous variant prime–boost regimens on humoral responses, focusing on intramuscular (IM) and intranasal (IN) routes of administration. Using a murine model, we assessed the immunogenicity of unadjuvanted protein boosts with Wu-1, Omicron BA.4/5, or Wu-1 + BA.4/5 spike antigens following monovalent or bivalent IM priming with mRNA-LNP vaccines. Results: IM priming induced strong systemic total and neutralizing antibody responses that were further enhanced by IN boosts with BA.4/5. IN boosting achieved the broadest serum neutralization across all VOCs tested. Notably, bivalent mRNA-LNP IM priming induced robust, cross-variant serum neutralizing antibody production, independent of subsequent IN boost combinations. Conclusions: Our findings highlight the benefit of including distinct antigenic variants in the prime vaccination followed by a variant-tailored IN boost to elicit both systemic and mucosal variant-specific responses that are potentially capable of reducing SARS-CoV-2 transmission.Keywords
Funding Information
- Canadian Institute of Health Research (CIHR) (VR2-172722, 476885)
- COVID-19 Immunity Task Force (CITF) (VR2-172722, 476885)
- Queen Elizabeth II Scholarship in Science and Technology (VR2-172722, 476885)
This publication has 119 references indexed in Scilit:
- Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamstersEuropean Journal of Immunology, 2024
- Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 StrainsJAMA Network Open, 2022
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Cell, 2022
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022
- A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccinationClinical & Translational Immunology, 2022
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityJAMA, 2021
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2Cell, 2020
- Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10Cell, 2019
- The function of immunoglobulin A in immunityThe Journal of Pathology, 2005